Abstract: The present invention pertains to implantable or insertable medical devices which comprise a substrate and one or more therapeutic-agent-containing regions contain one or more therapeutic agents. In various aspects of the invention, one or more characteristics of such therapeutic-agent-containing regions are controlled. Further aspects of the invention relate to methods of forming such devices and to methods of using such devices.

Abstract: According to an aspect of the invention, medical devices are provided, which include a nanoparticle-derived inorganic layer disposed over a least a portion of structure that includes a substrate, and optionally, a therapeutic-agent-containing layer disposed over at least a portion of the substrate. In some embodiments, the inorganic layer is a nanoporous inorganic layer. Other aspects of the invention comprise methods for forming such medical device.

Abstract: A medical balloon may be configured by at least partially inflating the medical balloon and forming at least one primary lobe in the balloon. The primary lobe extends from a central portion of the balloon. The primary lobe may be manipulated to form at least two secondary lobes therefrom. The balloon may then be deflated and the secondary lobes wrapped around the balloon.

Abstract: A medical device for delivering a therapeutic agent is described comprising a stent comprising a sidewall and a plurality of struts, wherein at least one strut or strut portion comprises at least one node, wherein the expansion of the stent creates at least one web comprising a coating composition having a therapeutic agent, and wherein at least one node is configured to be associated with at least one web. A method for delivering a therapeutic agent to a body site is also described.

Abstract: The invention relates generally to an implantable medical device for delivering a therapeutic agent to the body tissue of a patient, and a method for making such a medical device. In particular, the invention pertains to an implantable stent, such as an intravascular stent, having a coating comprising an inorganic or ceramic oxide, metal or inert carbon and a plurality of reservoirs in such material that contain a therapeutic agent.

Abstract: The present invention is directed to methods, processes, and systems for delivering therapeutic agent to a medical device. Under some methods, processes, and systems of the invention, particles including a magnetic material and a therapeutic agent may be directed towards a medical device via magnetic attraction. In another embodiment particles including a magnetic material may force a therapeutic agent/solvent solution into porous matrix by using a magnetic attraction. In still another embodiment, a medical device having at least a portion thereof including a magnetic material is used to attract and adhere particles comprising magnetic material and therapeutic agent to a target surface of the medical device, wherein the particles are fused to the target surface.

Abstract: The invention relates generally to a medical device for delivering a therapeutic agent to the body tissue of a patient, and methods for making such a medical device. More particularly, the invention is directed to a stent, such as an intravascular stent, having an inner and outer coating compositions disposed thereon. In another embodiment, the inner coating composition and outer coating composition are separated by a barrier coating composition.

Abstract: The present invention is directed to methods and systems for aligning and coating a medical device during a single coating cycle. A first section of an applicator may apply a contact force to surfaces of the medical device. The contact force may align and remove surface irregularities from the medical device prior to coating the medical device with coating. The coating may be resident on a second section of the applicator.

Abstract: A system for reducing the diameter of a stent comprises a stent contracting assembly. The assembly comprises a plurality of blades, which define a diameter reduction chamber. The chamber has an open diameter configuration and a closed diameter configuration. The plurality of blades comprises active blades and floating blades, wherein each active blade is engaged to an actuation mechanism. The actuation mechanism is constructed and arranged to move each active blade from the open diameter configuration to the closed diameter configuration. Each floating blade is moved from the open diameter configuration to the closed diameter configuration only as a result of the movement of the active blades.

Abstract: The present invention is generally directed to implantable medical devices for delivering therapeutic agents to the body tissue of a patient and methods for making such medical devices. In particular, the present invention is directed to implantable medical devices, such as intravascular stents, having a surface that includes a plurality of cavities and a plurality of pores and a composition disposed in the pores and/or cavities, as well as, implantable medical devices, such as intravascular stents, having a surface that has a coating composition disposed on the surface, wherein the coating composition includes a plurality of cavities and a plurality of pores and another coating composition disposed in the pores and/or cavities.

Abstract: A medical balloon may be configured by at least partially inflating the medical balloon and forming at least one primary lobe in the balloon. The primary lobe extends from a central portion of the balloon. The primary lobe may be manipulated to form at least two secondary lobes therefrom. The balloon may then be deflated and the secondary lobes wrapped around the balloon.

Abstract: The present invention pertains to implantable or insertable medical devices which comprise a substrate and one or more therapeutic-agent-containing regions contain one or more therapeutic agents. In various aspects of the invention, one or more characteristics of such therapeutic-agent-containing regions are controlled. Further aspects of the invention relate to methods of forming such devices and to methods of using such devices.

Abstract: A medical balloon may be configured by at least partially inflating the medical balloon and forming at least one primary lobe in the balloon. The primary lobe extends from a central portion of the balloon. The primary lobe may be manipulated to form at least two secondary lobes therefrom. The balloon may then be deflated and the secondary lobes wrapped around the balloon.

Abstract: According to an aspect of the present invention a method is provided which a porous medical article is contacted with a solution that contains a therapeutic agent and a solvent in order to load the pores of the medical article, after which the solvent is sublimated.

Abstract: A system for reducing the diameter of a stent comprises a stent contracting assembly. The assembly comprises a plurality of blades, which define a diameter reduction chamber. The chamber has an open diameter configuration and a closed diameter configuration. The plurality of blades comprises active blades and floating blades, wherein each active blade is engaged to an actuation mechanism. The actuation mechanism is constructed and arranged to move each active blade from the open diameter configuration to the closed diameter configuration. Each floating blade is moved from the open diameter configuration to the closed diameter configuration only as a result of the movement of the active blades.

Abstract: A method of producing a tubular member which includes providing at least one micro-extruder configured to extrude at least one material and providing a surface configured to accept the material extruded from the micro-extruder.

Abstract: A medical balloon may be configured by at least partially inflating the medical balloon and forming at least one primary wing in the balloon. The primary wing extends from a central portion of the balloon. The primary wing may be manipulated to form a T-shaped wing therefrom. The balloon may then be deflated and the T-shaped wings wrapped around the balloon.

Abstract: A system for reducing the diameter of a stent comprises a stent contracting assembly. The assembly comprises a plurality of blades, which define a diameter reduction chamber. The chamber has an open diameter configuration and a closed diameter configuration. The plurality of blades comprises active blades and floating blades, wherein each active blade is engaged to an actuation mechanism. The actuation mechanism is constructed and arranged to move each active blade from the open diameter configuration to the closed diameter configuration. Each floating blade is moved from the open diameter configuration to the closed diameter configuration only as a result of the movement of the active blades.

Abstract: A system for protecting a coated reconfigurable medical implant is provided. This system may include a carrier device having a proximal end and a distal end and a reconfigurable deployable coated medical implant in physical communication with an implant carrying region of the carrier device. In this system the deployable medical implant may be coated with a coating positioned on an exposed surface of the deployable medical implant and the deployable medical implant may be reconfigurable from a first larger configuration to a second contracted configuration. For protecting the coating, the coated medical implant may be encased by a hollow deformable membrane when the deployable medical implant is in the first larger configuration and the membrane may define a cavity with a cross-section that is smaller than the external cross-section of the deployable medical implant. The medical implant may be crimped to its second contracted configuration while the hollow deformable membrane is in place.

Abstract: According to an aspect of the invention, medical devices are provided, which include a nanoparticle-derived inorganic layer disposed over a least a portion of structure that includes a substrate, and optionally, a therapeutic-agent-containing layer disposed over at least a portion of the substrate. In some embodiments, the inorganic layer is a nanoporous inorganic layer. Other aspects of the invention comprise methods for forming such medical device.